Today: 8 June 2026
Browse Category

ASX:MSB 3 October 2025 - 6 March 2026

Mesoblast Limited shares rise as Ryoncil launch puts $120 million sales target in play

Mesoblast Limited shares rise as Ryoncil launch puts $120 million sales target in play

Mesoblast shares rose 3% in early U.S. trading Friday after the company reported first-half revenue of $51.3 million, up from $3.2 million a year earlier, driven by Ryoncil sales. The company set a fiscal 2026 net revenue target of $110–$120 million for Ryoncil and said 49 transplant centers have been onboarded. Cash stood at $130 million as of Dec. 31. An adult trial for Ryoncil is expected to begin after ethics approval in March.
6 March 2026
·
Australia stock market today: ASX 200 closes higher as tech rebounds; BlueScope pushes back on $13.2b bid

Australia stock market today: ASX 200 closes higher as tech rebounds; BlueScope pushes back on $13.2b bid

The S&P/ASX 200 closed up 0.29% at 8,720.8, led by gains in tech and healthcare, while miners fell. BlueScope rejected a A$13.2 billion takeover bid from SGH and Steel Dynamics. Ansell shares dropped 6.2% as CEO Neil Salmon announced his retirement, with Nathalie Ahlström set to take over in February. The Australian dollar slipped to about 67 U.S. cents.
8 January 2026
·········
Australian Stock Market Today: ASX 200 Climbs 0.8% as Takeover Deals, CPI Shock and Retail Rout Shape 26 November 2025

Australian Stock Market Today: ASX 200 Climbs 0.8% as Takeover Deals, CPI Shock and Retail Rout Shape 26 November 2025

The S&P/ASX 200 rose 0.81% to 8,606.5 Wednesday, shrugging off a jump in annual inflation to 3.8%. Temple & Webster plunged 32% after weak revenue growth, while National Storage REIT surged nearly 20% on a $4 billion takeover bid. The Australian dollar climbed to US$0.6505. Miners and healthcare stocks led gains.
26 November 2025
·········
Mesoblast Stock Jumps on Ryoncil Milestone – Analysts See 40% Upside

Mesoblast Stock Jumps on Ryoncil Milestone – Analysts See 40% Upside

Mesoblast shares closed at $17.02 on Oct. 2, up 4.6% after the FDA-approved Ryoncil won permanent CMS reimbursement via a new J-code. The company confirmed its cell therapies are made from U.S. donors and not subject to tariffs. Wall Street consensus is “Buy” with a $24 average price target. Hedge funds have increased stakes, but overall institutional ownership remains low.
3 October 2025
··

Stock Market Today

  • India's Stock Market Offers Selective Investment Opportunities Despite Sideways Nifty Movement
    June 8, 2026, 5:58 AM EDT. Veteran fund manager Hiren Ved highlights that global capital is targeting artificial intelligence (AI) giants, yet India's stock market remains a selective arena for investors. Despite the Nifty index trading sideways over the past two years, individual stocks have delivered significant returns. Ved's insights emphasize the importance of discerning stock picking in India amid broader market stagnation.

Latest articles

Keel Stock in Focus Monday After $400M AI Debt Raise

Keel Stock in Focus Monday After $400M AI Debt Raise

8 June 2026
Keel Infrastructure shares rose 3.1% to $5.29 in pre-market trading after pricing an upsized $400 million convertible note deal to fund AI data-center expansion, partially recovering from Friday’s 13.5% drop driven by dilution concerns; the company aims to use proceeds for equipment deposits and hedging, with investors watching for future lease signings as the next key milestone.
MPS Shares Surge After Intesa Launches €30.6 Billion Offer

MPS Shares Surge After Intesa Launches €30.6 Billion Offer

8 June 2026
Banca Monte dei Paschi di Siena shares soared 10.91% to 9.921 euros after Intesa Sanpaolo launched an unsolicited €30.6 billion cash-and-share bid, offering a 12.5% premium and triggering takeover rules that block MPS from merging with Banco BPM without shareholder approval, as investors weigh regulatory hurdles, branch disposals, and the fight for control of key Italian financial assets.
Hyperscale Data Stock Faces 21-Cent Deadline After Friday’s 25% Slide

Hyperscale Data Stock Faces 21-Cent Deadline After Friday’s 25% Slide

8 June 2026
Hyperscale Data’s $0.21/share buyback offer sits 39% above Friday’s $0.1510 close, with the tender expiring late Monday and covering up to 5.1% of shares; the company cites a “material disconnect” with net book value at $0.26/share, while ending its ATM stock-sale program and holding $51.8M in Bitcoin as of May 31.
Zealand Pharma Shares Sink 25% After Trial Results

Zealand Pharma Shares Sink 25% After Trial Results

8 June 2026
Zealand Pharma shares plunged 26.02% to 241.40 Danish crowns after investors focused on a 19% discontinuation rate for Boehringer’s obesity drug survodutide in the SYNCHRONIZE-1 trial, far higher than the 2.9% for placebo, despite strong fat-loss data, making the stock the worst performer on Europe’s STOXX 600 in early trade.
Intel’s AI Stock Run Stalls; Monday Premarket Move Fails to Settle It

Intel’s AI Stock Run Stalls; Monday Premarket Move Fails to Settle It

8 June 2026
Intel shares rose 1.6% to $100.74 in pre-market trading Monday, partly rebounding from Friday’s 7.9% drop that followed a strong U.S. jobs report and a tech selloff; investors now face a key test as Intel’s AI partnerships with Foxconn and others lack visible orders or financial details, while options pricing signals potential for another 9% stock move this week amid inflation data and shifting rate expectations.
Go toTop